EPO attenuates inflammatory cytokines by Muller cells in diabetic retinopathy

Xia Lei, Jingfa Zhang, Jianfeng Shen, Liu Mei Hu, Yalan Wu, Lisha Mou, Guoxu Xu, Weiye Li, Guo Tong Xu

Research output: Contribution to journalArticle

Abstract

Diabetic retinopathy (DR) is a chronic, low-grade inflammatory disease. We aimed to investigate the regulatory effects of erythropoietin (EPO) on the inflammatory cytokine production by Muller cells under the condition of DR. The expression levels of TNF-alpha, IL-1beta, IL-6 and VEGF in cultured rat Muller cells were enhanced by 1 mM glyoxal. The elevated TNF-alpha and IL-1beta, but not IL-6 and VEGF, were decreased by 2 U/ml EPO as detected by real-time PCR and ELISA. Moreover, the activity of AP-1 but not NF-kappaB was modulated by glyoxal and EPO. Intravitreal injection of EPO performed 24 h prior to sacrifice significantly reduced TNF-alpha and IL-1beta production while moderately attenuating IL-6 and VEGF in the retinas of streptozotocininduced diabetic rats. Furthermore, Muller cells were identified as the main source of IL-1beta production as indicated by co-localization of IL-1beta and CRALBP in situ. These findings implicate therapeutic potential of EPO in the amelioration of inflammation in diabetic retinas.

Original languageEnglish (US)
Pages (from-to)201-211
Number of pages11
JournalFrontiers in Bioscience - Elite
Volume3 E
Issue number1
StatePublished - Jan 1 2011
Externally publishedYes

Fingerprint

Ependymoglial Cells
Diabetic Retinopathy
Erythropoietin
Cytokines
Glyoxal
Vascular Endothelial Growth Factor A
Interleukin-6
Tumor Necrosis Factor-alpha
Retina
Rats
Intravitreal Injections
NF-kappa B
Transcription Factor AP-1
Real-Time Polymerase Chain Reaction
Enzyme-Linked Immunosorbent Assay
Inflammation

Keywords

  • Activator Protein 1
  • Diabetic Retinopathy
  • Erythropoietin
  • IL-1beta
  • Inflammatory Cytokines
  • Muller Cells
  • TNF-alpha

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Lei, X., Zhang, J., Shen, J., Hu, L. M., Wu, Y., Mou, L., ... Xu, G. T. (2011). EPO attenuates inflammatory cytokines by Muller cells in diabetic retinopathy. Frontiers in Bioscience - Elite, 3 E(1), 201-211.

EPO attenuates inflammatory cytokines by Muller cells in diabetic retinopathy. / Lei, Xia; Zhang, Jingfa; Shen, Jianfeng; Hu, Liu Mei; Wu, Yalan; Mou, Lisha; Xu, Guoxu; Li, Weiye; Xu, Guo Tong.

In: Frontiers in Bioscience - Elite, Vol. 3 E, No. 1, 01.01.2011, p. 201-211.

Research output: Contribution to journalArticle

Lei, X, Zhang, J, Shen, J, Hu, LM, Wu, Y, Mou, L, Xu, G, Li, W & Xu, GT 2011, 'EPO attenuates inflammatory cytokines by Muller cells in diabetic retinopathy', Frontiers in Bioscience - Elite, vol. 3 E, no. 1, pp. 201-211.
Lei X, Zhang J, Shen J, Hu LM, Wu Y, Mou L et al. EPO attenuates inflammatory cytokines by Muller cells in diabetic retinopathy. Frontiers in Bioscience - Elite. 2011 Jan 1;3 E(1):201-211.
Lei, Xia ; Zhang, Jingfa ; Shen, Jianfeng ; Hu, Liu Mei ; Wu, Yalan ; Mou, Lisha ; Xu, Guoxu ; Li, Weiye ; Xu, Guo Tong. / EPO attenuates inflammatory cytokines by Muller cells in diabetic retinopathy. In: Frontiers in Bioscience - Elite. 2011 ; Vol. 3 E, No. 1. pp. 201-211.
@article{a2fdef97faff44298e7ff9619a383f61,
title = "EPO attenuates inflammatory cytokines by Muller cells in diabetic retinopathy",
abstract = "Diabetic retinopathy (DR) is a chronic, low-grade inflammatory disease. We aimed to investigate the regulatory effects of erythropoietin (EPO) on the inflammatory cytokine production by Muller cells under the condition of DR. The expression levels of TNF-alpha, IL-1beta, IL-6 and VEGF in cultured rat Muller cells were enhanced by 1 mM glyoxal. The elevated TNF-alpha and IL-1beta, but not IL-6 and VEGF, were decreased by 2 U/ml EPO as detected by real-time PCR and ELISA. Moreover, the activity of AP-1 but not NF-kappaB was modulated by glyoxal and EPO. Intravitreal injection of EPO performed 24 h prior to sacrifice significantly reduced TNF-alpha and IL-1beta production while moderately attenuating IL-6 and VEGF in the retinas of streptozotocininduced diabetic rats. Furthermore, Muller cells were identified as the main source of IL-1beta production as indicated by co-localization of IL-1beta and CRALBP in situ. These findings implicate therapeutic potential of EPO in the amelioration of inflammation in diabetic retinas.",
keywords = "Activator Protein 1, Diabetic Retinopathy, Erythropoietin, IL-1beta, Inflammatory Cytokines, Muller Cells, TNF-alpha",
author = "Xia Lei and Jingfa Zhang and Jianfeng Shen and Hu, {Liu Mei} and Yalan Wu and Lisha Mou and Guoxu Xu and Weiye Li and Xu, {Guo Tong}",
year = "2011",
month = "1",
day = "1",
language = "English (US)",
volume = "3 E",
pages = "201--211",
journal = "Frontiers in Bioscience - Elite",
issn = "1945-0494",
publisher = "Frontiers in Bioscience",
number = "1",

}

TY - JOUR

T1 - EPO attenuates inflammatory cytokines by Muller cells in diabetic retinopathy

AU - Lei, Xia

AU - Zhang, Jingfa

AU - Shen, Jianfeng

AU - Hu, Liu Mei

AU - Wu, Yalan

AU - Mou, Lisha

AU - Xu, Guoxu

AU - Li, Weiye

AU - Xu, Guo Tong

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Diabetic retinopathy (DR) is a chronic, low-grade inflammatory disease. We aimed to investigate the regulatory effects of erythropoietin (EPO) on the inflammatory cytokine production by Muller cells under the condition of DR. The expression levels of TNF-alpha, IL-1beta, IL-6 and VEGF in cultured rat Muller cells were enhanced by 1 mM glyoxal. The elevated TNF-alpha and IL-1beta, but not IL-6 and VEGF, were decreased by 2 U/ml EPO as detected by real-time PCR and ELISA. Moreover, the activity of AP-1 but not NF-kappaB was modulated by glyoxal and EPO. Intravitreal injection of EPO performed 24 h prior to sacrifice significantly reduced TNF-alpha and IL-1beta production while moderately attenuating IL-6 and VEGF in the retinas of streptozotocininduced diabetic rats. Furthermore, Muller cells were identified as the main source of IL-1beta production as indicated by co-localization of IL-1beta and CRALBP in situ. These findings implicate therapeutic potential of EPO in the amelioration of inflammation in diabetic retinas.

AB - Diabetic retinopathy (DR) is a chronic, low-grade inflammatory disease. We aimed to investigate the regulatory effects of erythropoietin (EPO) on the inflammatory cytokine production by Muller cells under the condition of DR. The expression levels of TNF-alpha, IL-1beta, IL-6 and VEGF in cultured rat Muller cells were enhanced by 1 mM glyoxal. The elevated TNF-alpha and IL-1beta, but not IL-6 and VEGF, were decreased by 2 U/ml EPO as detected by real-time PCR and ELISA. Moreover, the activity of AP-1 but not NF-kappaB was modulated by glyoxal and EPO. Intravitreal injection of EPO performed 24 h prior to sacrifice significantly reduced TNF-alpha and IL-1beta production while moderately attenuating IL-6 and VEGF in the retinas of streptozotocininduced diabetic rats. Furthermore, Muller cells were identified as the main source of IL-1beta production as indicated by co-localization of IL-1beta and CRALBP in situ. These findings implicate therapeutic potential of EPO in the amelioration of inflammation in diabetic retinas.

KW - Activator Protein 1

KW - Diabetic Retinopathy

KW - Erythropoietin

KW - IL-1beta

KW - Inflammatory Cytokines

KW - Muller Cells

KW - TNF-alpha

UR - http://www.scopus.com/inward/record.url?scp=79952666872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952666872&partnerID=8YFLogxK

M3 - Article

C2 - 21196299

AN - SCOPUS:79952666872

VL - 3 E

SP - 201

EP - 211

JO - Frontiers in Bioscience - Elite

JF - Frontiers in Bioscience - Elite

SN - 1945-0494

IS - 1

ER -